Jakobsen Ane Storch, Speyer Helene, Nørgaard Hans Christian Brix, Karlsen Mette, Birk Merete, Hjorthøj Carsten, Mors Ole, Krogh Jesper, Gluud Christian, Pisinger Charlotta, Nordentoft Merete
Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.
Institute of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
PLoS One. 2017 Oct 6;12(10):e0185881. doi: 10.1371/journal.pone.0185881. eCollection 2017.
The objective of this trial was to assess the long-term effect of the CHANGE lifestyle coaching intervention for 428 people with abdominal obesity and schizophrenia spectrum disorders on cardiovascular risk. In this randomized, superiority, multi-center clinical trial, participants were randomized to 12 months of either lifestyle coaching plus care coordination (N = 138), care coordination alone, (N = 142) or treatment as usual (N = 148). There was no effect after 12 months, but we hypothesized that there might have been a delayed treatment effect. Our primary outcome at two-year follow-up was 10-year risk of cardiovascular disease standardized to 60 years of age. After two-years the mean 10-year cardiovascular-disease risk was 8.7% (95% confidence interval (CI) 7.6-9.9%) in the CHANGE group, 7.7% (95% CI 6.5-8.9%) in the care coordination group, and 8.9% (95% CI 6.9-9.2%) in the treatment as usual group (P = 0.24). Also, there were no intervention effects for any secondary or exploratory outcomes, including cardiorespiratory fitness, weight, physical activity, diet and smoking. No reported adverse events could be ascribed to the intervention. We conclude that there was neither any direct nor any long-term effect of individual lifestyle coaching or care coordination on cardiovascular risk factors in people with abdominal obesity and schizophrenia spectrum disorders. The trial was approved by the Ethics Committee of Capitol Region Copenhagen, Denmark (registration number: H-4-2012-051) and the Danish Data Protection Agency (registration number: 01689 RHP-2012-007). The trial was funded by the Mental Health Services of the Capital Region of Denmark, the Lundbeck Foundation, the Tryg Foundation, the Danish Ministry of Health, and the Dæhnfeldts Foundation.
本试验的目的是评估CHANGE生活方式指导干预措施对428名腹部肥胖且患有精神分裂症谱系障碍的患者心血管风险的长期影响。在这项随机、优效性、多中心临床试验中,参与者被随机分为三组,分别接受为期12个月的生活方式指导加护理协调(N = 138)、仅护理协调(N = 142)或常规治疗(N = 148)。12个月后未观察到效果,但我们推测可能存在延迟治疗效果。我们在两年随访时的主要结局是标准化到60岁的10年心血管疾病风险。两年后,CHANGE组的平均10年心血管疾病风险为8.7%(95%置信区间[CI] 7.6 - 9.9%),护理协调组为7.7%(95% CI 6.5 - 8.9%),常规治疗组为8.9%(95% CI 6.9 - 9.2%)(P = 0.24)。此外,对于任何次要或探索性结局,包括心肺适能、体重、身体活动、饮食和吸烟,均未观察到干预效果。未报告可归因于该干预措施的不良事件。我们得出结论,个体生活方式指导或护理协调对腹部肥胖且患有精神分裂症谱系障碍的患者的心血管危险因素既无直接影响也无长期影响。该试验获得了丹麦哥本哈根首都地区伦理委员会(注册号:H-4-2012-051)和丹麦数据保护局(注册号:01689 RHP-2012-007)的批准。该试验由丹麦首都地区精神卫生服务局、伦贝克基金会、Tryg基金会、丹麦卫生部和戴恩费尔特斯基金会资助。